SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,005.01 1,223.12
( 1.68%)

Global Indices

Nasdaq

51,633.03 -58.07
(-0.11%)

Dow Jones

7,740.63 -85.82
(-1.10%)

Hang Seng

67,780.30 2.78
(0.00%)

Nikkei 225

10,730.66 80.33
(0.75%)

Forex

USD-INR

95.22 -0.47
(-0.50%)

EUR-INR

106.51 -0.49
(-0.46%)

GBP-INR

126.04 -0.53
(-0.42%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

43.3828165

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

13.86

220.66

EPS(TTM)

Face Value()

Div & Yield %

10.08

0.5

Back

bajaj finance ltd

Uflex consolidated net profit rises 629.63% in the June 2026 quarter

Aug 15,2026

Net profit of Uflex rose 629.63% to Rs 423.33 crore in the quarter ended June 2026 as against Rs 58.02 crore during the previous quarter ended June 2025. Sales rose 35.52% to Rs 5201.23 crore in the quarter ended June 2026 as against Rs 3837.90 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5201.23	3837.90	36
OPM %	17.09	11.82	-
PBDT	704.38	276.06	155
PBT	491.37	89.34	450
NP	423.33	58.02	630

74,005.01 1,223.12 ( 1.68%)

51,633.03 -58.07 (-0.11%)

7,740.63 -85.82 (-1.10%)

67,780.30 2.78 (0.00%)

10,730.66 80.33 (0.75%)

95.22 -0.47 (-0.50%)

106.51 -0.49 (-0.46%)

126.04 -0.53 (-0.42%)

0.60 0.00 (-0.36%)